Disease · MONDO_0005276
dental caries
6 sourcesdiseases-2026-09-18-0.1.0
Cite this record
ConductScience Library. dental caries. Diseases, record MONDO_0005276. Release diseases-2026-09-18-0.1.0, 18 Sept 2026. https://conductscience.org/library/diseases/MONDO_0005276
On this page
Disease
Names and IDs as Open Targets gives them. Its IDs in MeSH, Orphanet, the Disease Ontology and the NCI Thesaurus are those Open Targets states for it.
- Other names
CARIES DENT, Caries, Dental, DECAY DENT, DENT CARIES, DENT DECAY, DENT WHITE SPOT, DENT WHITE SPOTS, Decay, Dental, Dental Decay, Dental White Spot, Dental White Spots, Spot, White, Spots, White, WHITE SPOT DENT, WHITE SPOTS DENT, White Spot, White Spot, Dental, White Spots, White Spots, Dental, caries
- Open Targets
Drugs38
The drugs Open Targets' clinical reports study for the disease, the highest stage first, then the most trial reports. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.
| Drug | ChEMBL ID | Type | Open Targets' stage | Stage reported by | Reports | Of them trials | Trials shown here | Source |
|---|---|---|---|---|---|---|---|---|
| SODIUM FLUORIDE | CHEMBL1528 | Small molecule | Approval | DailyMed | 53 | 24 | 23 | Drugs and targets |
| SODIUM MONOFLUOROPHOSPHATE | CHEMBL1908359 | Small molecule | Approval | DailyMed | 22 | 6 | 6 | Drugs and targets |
| STANNOUS FLUORIDE | CHEMBL1909079 | Small molecule | Approval | DailyMed | 12 | 2 | 2 | Drugs and targets |
| SILVER DIAMMINE FLUORIDE | CHEMBL4297206 | Small molecule | Phase 3 | ClinicalTrials.gov | 26 | 26 | 26 | Drugs and targets |
| CHLORHEXIDINE | CHEMBL790 | Small molecule | Phase 3 | ClinicalTrials.gov | 9 | 9 | 9 | Drugs and targets |
| SILVER NITRATE | CHEMBL177367 | Small molecule | Phase 3 | ClinicalTrials.gov | 3 | 3 | 3 | Drugs and targets |
| ARGININE | CHEMBL1485 | Small molecule | Phase 3 | ClinicalTrials.gov | 2 | 2 | 2 | Drugs and targets |
| POLIGLUSAM | CHEMBL2108133 | Small molecule | Phase 3 | ClinicalTrials.gov | 1 | 1 | 1 | Drugs and targets |
| TITANIUM DIOXIDE | CHEMBL1201136 | Small molecule | Phase 3 | ClinicalTrials.gov | 1 | 1 | 1 | Drugs and targets |
| FLUORIDE | CHEMBL1232767 | Small molecule | Phase 2/3 | ClinicalTrials.gov | 13 | 13 | 12 | Drugs and targets |
1 to 10 of 38
See all 38 drugsTargets3
The targets ChEMBL's mechanism records give for the disease's drugs, through Open Targets, the most drugs first. A mechanism record says what a drug acts on, not that the target causes the disease.
| Target | Protein | Its drugs that act on it | Mechanisms | Highest stage of those drugs | Gene in Genes | Source |
|---|---|---|---|---|---|---|
| HMGCR | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 1 | HMG-CoA reductase inhibitor | Phase 1 | https://conductscience.org/library/genes/3156 | Drugs and targets |
| MTNR1A | Melatonin receptor | 1 | Melatonin receptor agonist | Unknown | https://conductscience.org/library/genes/4543 | Drugs and targets |
| MTNR1B | Melatonin receptor | 1 | Melatonin receptor agonist | Unknown | https://conductscience.org/library/genes/4544 | Drugs and targets |
Trials77
Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs. 2 more are not shown, since the checks do not confirm them.
| Trial | Title | Phase | Participants | Results first posted | Conditions | Drugs | Linked by | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02492841 | Calcium Hydroxide, Mineral Trioxide Aggregate and Biodentine (Trademark) as Direct Pulp Capping of Permanent Teeth | Phase 2/3 | 169 | 2017-08-14 | Caries, Dental Pulp Exposure | CALCIUM HYDROXIDE | Its record names the disease | ClinicalTrials.gov |
| NCT01657877 | Anti-caries Potential of a Sodium Monofluorophosphate and Calcium Sodium Phosphosilicate Dentifrice | Phase 2 | 100 | 2014-07-24 | Caries | CALCIUM SODIUM PHOSPHOSILICATE, SODIUM MONOFLUOROPHOSPHATE | Its record names the disease | ClinicalTrials.gov |
| NCT02399163 | Evaluation of Oral Hygiene Products in an In Situ Caries Model | Not applicable | 80 | 2016-05-12 | Dental Caries | FLUORIDE | Its record names the disease | ClinicalTrials.gov |
| NCT02536040 | Stopping Cavities Study: Diammine Silver Fluoride | Phase 3 | 66 | 2020-01-23 | Dental Caries | SILVER DIAMMINE FLUORIDE | Its record names the disease | ClinicalTrials.gov |
| NCT01005966 | In Situ Caries Model of Fluoride Toothpastes | Phase 3 | 65 | 2013-07-29 | Caries | SODIUM FLUORIDE, SODIUM MONOFLUOROPHOSPHATE | Its record names the disease | ClinicalTrials.gov |
| NCT01563172 | Effect of Dentifrice Usage Regime on Delivery and Efficacy of Fluoride | Phase 4 | 65 | 2017-08-10 | Dental Caries | SODIUM FLUORIDE | Its record names the disease | ClinicalTrials.gov |
| NCT02195583 | The Effect of Experimental Dentifrices on Remineralization of Caries Lesions In-situ | Not applicable | 62 | 2015-04-07 | Oral Hygiene | SODIUM FLUORIDE | Its record names the disease | ClinicalTrials.gov |
| NCT04399161 | Anticaries Effect of Xylitol,Probiotic and Chlorhexidine Mouth Rinses Among Individuals at High Risk | Phase 2/3 | 60 | 2020-07-22 | Cariostatic Agents, Mouthwashes | CHLORHEXIDINE, XYLITOL | Its record names the disease | ClinicalTrials.gov |
| NCT02751320 | Efficacy of Three Toothpastes Using an in Situ Caries Model | Not applicable | 58 | 2017-10-13 | Dental Caries | FLUORIDE, PHYTATE, SODIUM CITRATE, ZINC CHLORIDE | Its record names the disease | ClinicalTrials.gov |
| NCT00708097 | In Situ Caries Efficacy of Fluoride Toothpastes | Phase 3 | 57 | 2013-06-24 | Caries | SODIUM FLUORIDE, SODIUM MONOFLUOROPHOSPHATE | Its record names the disease | ClinicalTrials.gov |
1 to 10 of 77
See all 77 trialsComparisons in its trials4
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| 38% Diamine Silver Fluoride vs Water: deaths from any cause | 0 of 29 | 0 of 35 | 64 | NCT02536040 | Trial comparisons |
| 38% Diamine Silver Fluoride vs Water: serious adverse events | 0 of 29 | 0 of 35 | 64 | NCT02536040 | Trial comparisons |
| Nano Silver Fluoride Solution vs Cavity Cleanser: deaths from any cause | 0 of 22 | 0 of 22 | 44 | NCT03186261 | Trial comparisons |
| Nano Silver Fluoride Solution vs Cavity Cleanser: serious adverse events | 0 of 22 | 0 of 22 | 44 | NCT03186261 | Trial comparisons |
Papers from its trials36
The papers the trials shown here list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.
Data dates
The date of each source this release read.
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this disease from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0005276
GET https://conductscience.org/api/diseases/v1/MONDO_0005276/drugs?page=2